Financial Performance - The company reported a revenue of RMB 715 million for the fiscal year ending March 31, 2025, with a 10.3% year-on-year growth in revenue from its big data platform and solutions segment, which generated RMB 346 million [1] - The annual loss was reduced to RMB 135 million, representing a 38.9% decrease in losses compared to the previous year [1] - Cash management improvements led to a 23.8% year-on-year narrowing of net cash outflow from operating activities, with total cash reserves amounting to RMB 3.309 billion as of March 31, 2025 [1] Technological Advancements - The company has made significant progress in developing its self-researched medical domain large model technology, YiduCore, which has established a comprehensive barrier across the "data - computing power - algorithm - scenario" chain [2] - YiduCore has processed 1.15 billion patient visits and 6 billion authorized medical records, creating a disease knowledge graph that covers all known human diseases [2] - The company is the first in the medical field to achieve full-link adaptation of high-end chips domestically and internationally, supporting breakthroughs in algorithm efficiency [2] Market Position and Client Engagement - As of March 31, 2025, the company provided solutions to 110 top hospitals in China and 44 regulatory agencies, covering over 4,000 hospitals [3] - The company has upgraded its AI platform and EYWA data platform to versions 2.0 and 5.0, respectively, and launched new platforms tailored for hospital management and research needs [3] - The life sciences solutions segment serves 132 clients, with a revenue retention rate of 87.51% among the top 20 clients, including 16 of the top 20 multinational pharmaceutical companies [3] Health Management Solutions - The company has maintained a leading position in core cities, serving as the main operating platform for the "Shenzhen Health Insurance" program for three consecutive years, with 6.09 million insured individuals in 2024 [3] - It has also been the main operating platform for the "Beijing Health Insurance" program for four consecutive years, with cumulative insured individuals exceeding 15 million [3] - The active user count on the company's health management platform, who have completed at least one transaction, exceeds 24 million [3]
医渡科技(02158.HK)年度业绩：大数据平台和解决方案收入保持平稳增长，年度亏损同比大幅减亏38.9%